UBS AM’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-59,656
| Closed | -$969K | – | 2856 |
|
|
2021
Q4 | $969K | Hold |
59,656
| – | – | ﹤0.01% | 2225 |
|
|
2021
Q3 | $906K | Hold |
59,656
| – | – | ﹤0.01% | 2219 |
|
|
2021
Q2 | $1.03M | Buy |
59,656
+8,755
| +17% | +$161K | ﹤0.01% | 2202 |
|
|
2021
Q1 | $994K | Hold |
50,901
| – | – | ﹤0.01% | 2096 |
|
|
2020
Q4 | $1.02M | Buy |
50,901
+4,833
| +10% | +$98.8K | ﹤0.01% | 1982 |
|
|
2020
Q3 | $826K | Sell |
46,068
-14,666
| -24% | -$359K | ﹤0.01% | 1919 |
|
|
2020
Q2 | $1.64M | Buy |
60,734
+5,964
| +11% | +$164K | ﹤0.01% | 1596 |
|
|
2020
Q1 | $1.35M | Buy |
54,770
+11,467
| +26% | +$418K | ﹤0.01% | 1578 |
|
|
2019
Q4 | $2.26M | Sell |
43,303
-1,584
| -4% | -$72.5K | ﹤0.01% | 1547 |
|
|
2019
Q3 | $1.8M | Buy |
44,887
+8,707
| +24% | +$401K | ﹤0.01% | 1658 |
|
|
2019
Q2 | $1.73M | Buy |
36,180
+9,341
| +35% | +$376K | ﹤0.01% | 1665 |
|
|
2019
Q1 | $1.48M | Buy |
26,839
+900
| +3% | +$42.8K | ﹤0.01% | 1666 |
|
|
2018
Q4 | $946K | Buy |
25,939
+8,866
| +52% | +$363K | ﹤0.01% | 1779 |
|
|
2018
Q3 | $847K | Hold |
17,073
| – | – | ﹤0.01% | 1876 |
|
|
2018
Q2 | $755K | Buy |
17,073
+4,781
| +39% | +$197K | ﹤0.01% | 1922 |
|
|
2018
Q1 | $492K | Sell |
12,292
-138
| -1% | -$5.47K | ﹤0.01% | 2042 |
|
|
2017
Q4 | $498K | Buy |
+12,430
| New | +$478K | ﹤0.01% | 1975 |
|
UBS AM's ZGNX Position: Q1 2022 in Review
UBS AM sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 59,656 shares — an estimated $969K sold.
UBS AM first reported a position in ZGNX in Q4 2017 and held it in 17 quarters. The position peaked at $2.26M in Q4 2019. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- UBS AM reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- UBS AM sold 59,656 Zogenix, Inc. shares in Q1 2022, an estimated $969K.
- UBS AM first reported a position in Zogenix, Inc. in Q4 2017 and held it in 17 quarters.
- UBS AM's Zogenix, Inc. position peaked at $2.26M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.